The Latest Cardiac and Vascular News
The U.S. pivotal study will evaluate FastWave’s electric IVL system in patients with peripheral artery disease. MINNEAPOLIS, Aug. 11, 2026 /PRNewswire/ — FastWave Medical, which is developing next-generation intravascular lithotripsy (IVL) technology, has received FDA approval of its Investigational Device Exemption (IDE) application, which clears the company to begin a U.S. pivotal trial of its ArteroTM electric IVL […]
Newly issued patents in Australia and Japan cover the company’s Artero™ E-IVL and Sola™ L-IVL platforms as FastWave advances toward peripheral and coronary IDE trials. MINNEAPOLIS, May 19, 2026 /PRNewswire/ — FastWave Medical has added four international patents to its intellectual…
Successful study enrollment and patent issuance highlight FastWave’s continued momentum with its Sola™ coronary laser intravascular lithotripsy platform. MINNEAPOLIS, Nov. 11, 2025 /PRNewswire/ — FastWave Medical successfully completed enrollment in its 30-patient coronary feasibility…
Findings demonstrate safety, procedural success, and imaging-confirmed calcium modification using a next-generation laser intravascular lithotripsy (IVL) platform. MINNEAPOLIS, Oct. 29, 2025 /PRNewswire/ — FastWave Medical presented new first-in-human (FIH) and pre-clinical data for its…
Renowned endovascular specialists from Columbia and Stanford to guide pivotal trial of Artero™ electric IVL system. MINNEAPOLIS, Sept. 30, 2025 /PRNewswire/ — FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, today announced the appointment of its principal…
Initial FIH procedures launch FastWave’s multi-center feasibility study evaluating the safety and performance of its laser-based coronary IVL platform. MINNEAPOLIS, June 3, 2025 /PRNewswire/ — FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, today announced the…
Feasibility study for coronary artery disease will commence ahead of FastWave’s expected U.S. pivotal trial. MINNEAPOLIS, May 7, 2025 — FastWave Medical, a pioneering intravascular lithotripsy (IVL) startup, has secured Institutional Review Board (IRB) approval to commence a coronary feasibility study utilizing SolaTM, its novel laser IVL (L-IVL) […]
